Research Laboratory of Hepatobiliary Diseases, Second Xiangya Hospital, Central South University, 139# Middle Renmin road, Changsha, Hunan, 410011, China.
Cell Tissue Res. 2014 Feb;355(2):365-74. doi: 10.1007/s00441-013-1752-1. Epub 2013 Dec 6.
Epithelial-mesenchymal transitions (EMTs) are essential manifestations of epithelial cell plasticity during tumor progression. Transforming growth factor-β(TGF-β) modulates epithelial plasticity in tumor physiological contexts by inducing EMT, which is associated with the altered expression of genes. In the present study, we used DNA micro-array analysis to search for differentially expressed genes in the TGF-β1 induced gallbladder carcinoma cell line (GBC-SD cells), as compared with normal GBC-SD cells. We identified 225 differentially expressed genes, including 144 that were over-expressed and 81 that were under-expressed in the TGF-β1 induced GBC-SD cells. NT5E (CD73) is the most increased gene, while the Fc fragment of the IgG binding protein (FcGBP) is the most decreased gene. The expression patterns of these two genes in gallbladder adenocarcinoma and chronic cholecystitis tissue were consistent with the micro-array data. Immunochemistry and clinicopathological results showed that the expression of NT5E and FcGBP in gallbladder adenocarcinoma is an independent marker for evaluation of the disease progression, clinical biological behaviors and prognosis. The data from the current study indicate that differential NT5E and FcGBP expressions could be further evaluated as biomarkers for predicting survival of patients with gallbladder cancer and that NT5E and FcGBP could be promising targets in the control of gallbladder cancer progression.
上皮-间充质转化(EMT)是肿瘤进展过程中上皮细胞可塑性的重要表现。转化生长因子-β(TGF-β)通过诱导 EMT 来调节肿瘤生理环境中的上皮可塑性,这与基因表达的改变有关。在本研究中,我们使用 DNA 微阵列分析来搜索 TGF-β1 诱导的胆囊癌细胞系(GBC-SD 细胞)与正常 GBC-SD 细胞之间差异表达的基因。我们鉴定出 225 个差异表达的基因,包括 144 个上调基因和 81 个下调基因。NT5E(CD73)是表达上调最显著的基因,而 IgG 结合蛋白 Fc 片段(FcGBP)是表达下调最显著的基因。这两个基因在胆囊腺癌和慢性胆囊炎组织中的表达模式与微阵列数据一致。免疫组织化学和临床病理结果表明,胆囊腺癌中 NT5E 和 FcGBP 的表达是评估疾病进展、临床生物学行为和预后的独立标志物。本研究的数据表明,差异表达的 NT5E 和 FcGBP 可以进一步评估作为预测胆囊癌患者生存的生物标志物,并且 NT5E 和 FcGBP 可能是控制胆囊癌进展的有前途的靶点。